The Federal Bureau of Investigation is looking into media trading and transparency in the US advertising market.
WPP's Read: We're focusing on collaboration, rather than 'collapsing' agency brands and restructuring
Mark Read has warned against "collapsing" too many WPP agency brands and said driving greater collaboration is more important than a "major restructuring".
Rishi Shah stepped down from the chief executive position five months ago amid fraud allegations.
In the week that former WPP chief Sir Martin Sorrell faced claims of bullying behaviour and paying for a prostitute, the ad group will be breathing a sigh of relief after an AGM that avoided a showdown.
The WPP agency is hoping its reorganization results in more collaboration among health and wellness staffers.
WPP faced tough questions about Sir Martin Sorrell's exit at its annual general meeting, with more than a quarter of WPP shareholders voting against his entitlement to a possible $26.7 million pay-off.
WPP joint COO Mark Read has emailed all staff at the group to tell them to expect respect from their colleagues and announce a group-wide code of conduct review.
Martin Sorrell's reputation is under increasing fire from the press, with both the 'Financial Times' and the 'Daily Mail' using their front pages to air allegations about his conduct today.
WPP's unpublished investigation into its former chief executive Martin Sorrell's conduct examined whether he used company funds to pay a prostitute, according to reports.
WPP investors are set to lodge a significant protest over Sir Martin Sorrell's pay-off but executive chairman Roberto Quarta is expected to survive.
Former JWT global chief executive Gustavo Martinez has departed WPP in a sign that the ad group's new leadership wants to draw a line under his controversial tenure.
Investor pressure is likely to force WPP into selling Kantar, possibly along with other assets - which could open opportunities for Sir Martin Sorrell's new vehicle S4 Capital.
Just after the launch of Marcel, Publicis chief executive Arthur Sadoun was bombarded with questions from a packed room of clients, staff, and journalists.
AstraZeneca VP, head of U.S. oncology, Olivier Nataf details how being a company lifer impacted his career.
Two touted products in the pipeline reflect three of medical marketing's most profound modern-era challenges.